FDA approves Rocket gene therapy for rare immune disorder
Posted:
The Food and Drug Administration approved a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable to life-threatening infections.
We are pleased to welcome genedrive as a sponsor and exhibitor at this year’s GIANT Health Event.
Based in Manchester, genedrive is a diagnostics company developing rapid pharmacogenetic testing solutions designed to support safer, more effective prescribing decisions. By helping…
As healthcare systems continue to evolve, ensuring that new technologies deliver real value for patients, professionals, and the wider health and care system is more important than ever.
At GIANT Health, we are pleased to highlight our exhibitor Health Technology…
Attendees
Sponsors and Exhibitors
Contact us